Danaher DHR
NYSE DHR
$227.56 -1.02 (-0.45%)
At close: Nov 19, 2026 · 4:02 PM EST

Danaher (DHR) EBITDA Margin (2009 - 2026)

Updated

Danaher (DHR) reported EBITDA Margin of 30.00% for Q3 2026, up 0.66 percentage points from 29.34% a year earlier and up 1.49 percentage points from the prior quarter.

Analysis

Danaher (DHR) EBITDA Margin (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 25, 2026, Danaher's EBITDA Margin came in at 30.66%, up 1.68 percentage points year-over-year; for FY2025, it came in at 29.06%, down 1.16 percentage points from FY2024.

  • EBITDA Margin has declined for three consecutive years, though with a five-year change of +2.11 percentage points (FY2020 to FY2025).
  • By year, EBITDA Margin came in at 30.22% in FY2024 (-0.66 pp), 30.88% in FY2023 (-5.41 pp), 36.29% in FY2022 (+2.26 pp) and 34.03% in FY2021 (+7.07 pp).
  • Five-year quarterly EBITDA Margin spans a low of 23.10% in Q2 2025 and a high of 44.24% in Q4 2021.
  • Year over year, EBITDA Margin has now increased in each of the last five quarters, with an average year-over-year change of +0.39 percentage points over the last eight quarters.
  • The high point for year-over-year EBITDA Margin in five years was Q4 2021 (a gain of 13.04 percentage points); the low point was Q4 2022 (a drop of 9.59 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at 28.51% (Q2 2026), 33.12% (Q1 2026) and 31.12% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 247.92 Bn 224.44 Bn 5.13 Bn 25.44%
2 Abbott Laboratories 178.73 Bn 152.60 Bn 7.39 Bn 20.09%
3 Danaher 155.17 Bn 134.82 Bn 3.84 Bn 30.00%
4 Intuitive Surgical 139.71 Bn 120.00 Bn 2.08 Bn 25.90%
5 Medtronic 127.92 Bn 93.17 Bn 6.34 Bn 25.55%
6 Stryker 118.34 Bn 104.53 Bn 4.25 Bn 20.38%
7 Boston Scientific 61.10 Bn 56.53 Bn 3.43 Bn 23.14%
8 Edwards Lifesciences 58.81 Bn 42.02 Bn 1.35 Bn 20.05%
9 Agilent Technologies 47.86 Bn 40.75 Bn 1.04 Bn 27.16%
10 Nuo Therapeutics 44.28 Bn 44.28 Bn 1.19 Mn -18.22%
Historic Data

Historic Data

Download Data
DateValue
Sep 25, 2026 30.00%
Jun 26, 2026 28.51%
Mar 27, 2026 33.12%
Dec 31, 2025 31.12%
Sep 26, 2025 29.34%
Jun 27, 2025 23.10%
Mar 28, 2025 32.49%
Dec 31, 2024 30.90%
Sep 27, 2024 26.72%
Jun 28, 2024 30.44%
Mar 29, 2024 32.75%
Dec 31, 2023 29.73%
Sep 29, 2023 30.55%
Jun 30, 2023 28.81%
Mar 31, 2023 34.49%
Dec 31, 2022 34.65%
Sep 30, 2022 34.97%
Jul 1, 2022 37.42%
Apr 1, 2022 38.25%
Dec 31, 2021 44.24%
API Access

Danaher EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=DHR&period=max&api_key=YOUR_API_KEY